released: 10 Nov 2016 author: AIHW: Poulos LM, Ampon RD, Reddel HK, Hime N & Marks GB
This demonstration data linkage study investigates the use of lung function testing in the diagnosis and management of chronic airways disease. It uses data from the 45 and Up Study linked to Medicare Benefits Schedule (MBS) and Pharmaceutical Benefits Scheme (PBS) data. The study shows that: - contrary to recommended guidelines, most study participants (82%) initiated on medications for managing their chronic airways disease did not have lung function testing performed within 12 months, either before or after their initial prescription - among respondents who reported having current asthma, lung function testing was only claimed for about one-quarter (26%) in a recent 3-year period and 12% had only 1 lung function test claim during that time.
The evidence from this study will inform initiatives to help improve appropriate prescribing and health outcomes for people with chronic airways disease. This project also provides a demonstration of methods that could also potentially be used to fill evidence gaps associated with other chronic diseases such as diabetes, arthritis and cancer.
ISBN 978-1-76054-006-7; Cat. no. ACM 32; 42pp.; $10
Publication table of contents
- Preliminary material
- Title and verso pages
- Body section
- 1 Background
- Lung function testing
- Research questions
- 2 Methods
- 3 Use of lung function testing in people with chronic airways disease
- Question 1: What proportion of participants in the 45 and Up Study, with or without asthma, had lung function testing?
- Question 2: What proportion of people starting medications indicated for chronic airways disease had diagnostic lung function testing performed within +/- 12 months?
- 4 Discussion
- How key findings relate to Australian guidelines for asthma and COPD
- Limitations of the study
- The value of linked data-how this study will help
- End matter
- Appendix A: Data acquisition timeline
- List of tables
- List of figures
- Related publications
AIHW: Poulos LM, Ampon RD, Reddel HK, Hime N & Marks GB 2016. The use of lung function testing for the diagnosis and management of chronic airways disease. Cat. no. ACM 32. Canberra: AIHW.